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Abstract
Background: Cre-mediated site-specific integrative recombination in mouse embryonic stem (ES) cells is a useful tool 
for genome engineering, allowing precise and repeated site-specific integration. To promote the integrative reaction, a 
left element/right element (LE/RE) mutant strategy using a pair of lox sites with mutations in the LE or RE of the lox 
sequence has previously been developed. Recombination between LE and RE mutant lox produces a wild-type loxP 
site as well as an LE+RE double mutant lox site, which has mutations in both sides and less affinity to Cre, resulting in 
stable integration. We previously demonstrated successful integrative recombination using lox71 (an LE mutant) and 
lox66 (an RE mutant) in ES cells. Recently, other LE/RE mutant lox sites showing higher recombination efficiency in 
Escherichia coli have been reported. However, their recombination efficiency in mammalian cells remains to be 
analyzed.
Results: Using ES cells, we compared six RE mutant lox sites, focusing on their recombination efficiency with lox71. All 
of the RE mutant lox sites showed similar recombination efficiency. We then analyzed the stability of the recombined 
product, i.e., the LE+RE double mutant lox site, under continuous and strong Cre activity in ES cells. Two RE mutants, 
loxJTZ17 and loxKR3, produced more stable LE+RE double mutant lox than did the lox66/71 double mutant.
Conclusion: The two mutant RE lox sites, loxJTZ17 and loxKR3, are more suitable than lox66 for Cre-mediated 
integration or inversion in ES cells.
Background
The bacteriophage P1-derived Cre/lox recombination
system has been extensively used to engineer the genome
of experimental animals [1,2]. Cre recombinase recog-
nizes a 34-bp element, termed loxP, which is composed of
two 13-bp inverted repeats that serve as Cre binding
sites, and an 8-bp spacer region that participates in strand
exchange during recombination (Figure 1a) [3,4].
Depending on the relative orientation of the lox sites with
respect to one another, the recombination reaction can
result in excision, inversion, or integration.
Integrative recombination is useful for the production
of transgenic animals or cells because any DNA of inter-
est can be introduced into a chromosomally located lox
site. However, integrative recombination between wild-
type loxP sites is inefficient due to re-excision through
intramolecular recombination [5]. Studies of mutated
loxP sites have revealed that two classes of mutations can
promote Cre-mediated insertion or replacement. One
class consists of heterospecific lox sites carrying muta-
tion(s) in the central 8-bp spacer region [6-8]. Recombi-
nation does not occur between two lox sites differing in
the spacer region, whereas lox sites with identical spacer
regions can be recombined efficiently. Recombination
using heterospecific lox sites is termed "recombinase
mediated cassette exchange (RMCE)" [9], in which one
chromosomally preinserted DNA cassette flanked by two
different heterospecific lox sites is exchanged for another
cassette on a targeting plasmid flanked by the same kind
of heterospecific lox sites. To date, lox511 [10], lox2272
[11], and lox5171 [12] have been successfully used in
embryonic stem (ES) cells.
The other class is the left element/right element (LE/
RE) mutant strategy using LE mutant lox carrying muta-
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Page 2 of 9tions in the left-inverted repeat region and RE mutant lox
carrying mutations in the right-inverted repeat region
[13]. Recombination between an LE mutant lox and an
RE mutant lox results in the generation of a double
mutant lox site having mutations in both ends and a wild-
type loxP site. The double mutant lox site is not an effec-
tive substrate for Cre recombinase; therefore, the recom-
bination reaction proceeds exclusively in one direction
(Figure 1b). We have previously demonstrated successful
integrative recombination using lox71 (an LE mutant)
and lox66 (an RE mutant) in ES cells [14]. Moreover, two
other groups have used lox71/66 to induce unidirectional
Cre-mediated inversion [15,16].
Although the integrative recombination efficiency
using lox 71/66 is lower than RMCE efficiency using loxP
and lox2272 [17], the advantage of the LE/RE mutant lox
strategy is its simplicity. Only one LE or RE lox site is
required as a target for integrative recombination.
Recently, Thomson et al. performed mutational analysis
of LE/RE mutant lox sites using Escherichia coli and iden-
tified two novel LE/RE mutant lox, loxJT15 and loxJTZ17,
which showed approximately 1500-fold higher integra-
tion rates than lox71 and lox66 [18]. If these novel mutant
lox sites could also improve integration efficiency in ES
cells, they would be useful tools for Cre-mediated inte-
gration in mammalian genomes.
One application of the Cre/mutant lox integration sys-
tem is gene trapping in ES cells. Our group, as well as two
other groups (Database for Exchangeable Gene Trap
Clones, Sanger Institute Gene Trap Resources and Bay
Genomics), have constructed gene trap vectors incorpo-
rating a lox71 site and have generated over 20,000 gene
trap cell lines, which are available to the academic com-
munity through the International Gene Trap Consortium
database http://www.genetrap.org/index.html. With
these trap clones, any DNA of interest can be inserted
into a lox71 site and expressed under the control of the
trapped gene promoter [19]. Therefore, in this study, we
focused on screening for efficient RE mutant lox possess-
ing better recombination efficiency with the lox71 site.
Thomson et al. reported that the recombination effi-
ciency between loxJTZ17 and lox71 was 10 times higher
than that between lox66 and lox71. Although the 10-fold
promoting effect is less than the 1500-fold effect obtained
with loxJT15 and loxJTZ17, this improvement is consid-
ered sufficient because the recombination efficiency of
lox66 and lox71 in ES cells is 2-16% [14]. Here, we used
six RE mutant lox sites, including lox66, loxJTZ, and four
newly synthesized RE mutant lox sites(loxKR1-4), and
compared both their recombination efficiency and the
stability of recombined products in ES cells.
Results and Discussion
Mutant RE lox sites
We synthesized four new RE lox sites (loxKR1-4) as well
as loxJTZ17 (Figure 1c). LoxKR1 had four nucleotide
Figure 1 LE/RE mutant lox system. (a) Wild-type loxP sequence. The loxP site is composed of an asymmetric 8-bp spacer flanked by 13-bp inverted 
repeats that the Cre recombinase recognizes and binds to. (b) Integrative recombination with LE/RE mutant lox sites. The asterisks represent the mu-
tations. RE mutants have mutations in the right inverted repeat region, and LE mutants have mutations in the left inverted repeat region. Through 
recombination between LE and RE mutant lox sites, a wild-type loxP site and a double mutant lox site carrying mutations in both ends are produced. 
The double mutant lox site has a lower affinity for the Cre enzyme; therefore, recombination of the product rarely occurs, and the recombination re-
action tends toward integration. (c) Sequences of mutant lox sites used in this study. Lox71 carries 5 bp of mutation in the left element. The sequence 
of the right element of lox66 is complementary to the left element sequence of lox71. Mutated sequences are indicated by bold and are underlined.
Araki et al. BMC Biotechnology 2010, 10:29
http://www.biomedcentral.com/1472-6750/10/29
Page 3 of 9mutations; of these, three mutated nucleotides were the
same as the mutations in lox66, and one nucleotide was
the same as the mutation in loxJTZ17. LoxKR2-4 were
designed to have three mutations, as did loxJTZ17, but in
different positions.
Assessment of integrative recombination efficiency
To test whether these RE lox sites could promote recom-
bination efficiency in ES cells, we used the same strategy
as described previously [14](Figure 2a). For the chromo-
somal target lox71 site, the CAG promoter-lox71-bsr-pA
was introduced into ES cells. We isolated four ES
clones—Bs1, Bs17, Bs19, and Bs21—that carried a single
copy of the chromosomal target construct. Integration
vectors comprised an RE lox site on the 5' side of the pro-
moterless NLSlacZ gene and a selection marker gene,
MC1-neo-pA. The ES clones were coelectroporated with
the integration vector and the Cre-expression vector
pCAGGS-Cre (in their circular forms) and then selected
with G418. The cre gene was transiently expressed, medi-
ating site-specific recombination between the chromo-
somal lox71 and the RE lox on the integration plasmid;
this resulted in site-specific integration. The neo cassette
is active regardless of the integration site; therefore, both
random integrants and site-specific recombinants
become drug resistant. However, in the present study,
only the colonies where site-specific integration had
occurred were stained blue with 5-bromo-4-chloro-3-
indolyl β-D-galactopyranoside (X-gal) because the
NLSLacZ gene was inserted downstream of the CAG pro-
moter through Cre-mediated recombination. As shown
in Figure 2b and 2c, most of the blue colonies were uni-
formly blue, indicating that recombination occurred in
the early stage of colony formation. The percentage of
blue colonies represented the frequency of site-specific
integration. When only the integration vector was elec-
troporated, no blue colonies appeared (Figure 2d).
Site-specific integration frequencies
We constructed six integration vectors harboring differ-
ent RE mutant lox and compared their recombination
frequencies. Percentages of blue colonies, i.e., site-spe-
cific integration frequencies, in the four ES lines are
shown in Table 1. The frequencies with the lox66-vector
were 11-14%, and all other RE lox sites showed similar or
slightly higher frequencies than were observed with
lox66. Site-specific integration rates relative to the fre-
quency with lox66 are shown in Figure 3. The differences
observed were within a factor of 2, and there were no sta-
tistically significant differences among the RE lox sites (p
= 0.37). Thus, the promoting effect of loxJTZ17 observed
in E. coli was not clearly evident in ES cells. All new RE
lox sites showed similar recombination efficiencies to
loxJTZ17 and lox66.
Figure 2 Evaluation of recombination efficiency. (a) Schematic ex-
perimental strategy. Four ES cell lines carrying a single copy of CAG 
promoter-lox71-bsr-pA were established and coelectroporated with 
an integration plasmid and the Cre expression vector, pCAGGS-Cre. Af-
ter G418 selection, the colonies were stained with X-gal, and the per-
centage of blue colonies was scored as the site-specific integration 
efficiency. (b) Example of X-gal staining. Bs17 ES cells were coelec-
troporated with pCAGGS-Cre and pKR3NZneo, selected with G418 for 
1 week, and then stained with X-gal. (c) Magnified photo of blue colo-
nies. Most of blue colonies were stained uniformly. (d) X-gal stained 
plate electroporated without pCAGGS-Cre. Bs17 ES cells were elec-
troporated with only pKR3NZneo. No blue colony appeared.
Figure 3 Relative integration efficiency. The efficiency obtained 
with the lox66 integration plasmid arbitrarily set at 1.
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expression
Why did loxJTZ17 not increase the frequency of site-spe-
cific integration in ES cells? The major difference
between the report by Thomson et al. [18] and the pres-
ent study is the differing species of host cells: prokaryotic
cells and eukaryotic cells, respectively. Prokaryotic cells
are much smaller than eukaryotic cells. In addition, their
genomic DNA is not separated by a nuclear membrane
and has a more open structure than eukaryotic cells.
Therefore, in prokaryotic cells, Cre proteins and lox sites
should exist in much higher concentrations and meet and
bind more frequently than in eukaryotic cells. The effi-
ciency of integrative recombination in the LE/RE mutant
lox system depends on the in-affinity of the LE+RE dou-
ble mutant lox site to Cre protein. In this environment of
prokaryotic cells, Cre proteins may be able to act on dou-
ble mutant lox sites with incomplete levels of in-affinity
for Cre protein. In our assay using ES cells and transient
expression of the cre gene, the chance of a collision
between Cre proteins and the lox site was much lower
than in prokaryotic cells, and the double mutant lox site
was exposed to Cre proteins for only a limited time.
Therefore, Cre proteins may have disappeared before
they could recombine loxP and LE+RE double mutant
lox.
If the ineffectiveness of loxJTZ17 recombination in ES
cells is due to the limited chance of a collision between
Cre protein and lox sites, prolonged expression of Cre
protein should affect the recognition and recombination
of LE+RE double mutant lox sites. Therefore, we decided
to examine the stability of LE+RE double mutant lox sites
in ES cells under the continuous presence of Cre protein.
The strategy used to evaluate the stability of the double
mutant lox is shown in Figure 4. We used a Transthy-
retine (Ttr) knockout ES line (Ttr-KO41) in which the
lox71-Pgk-neo-loxP-pA-lox2272 cassette was inserted
into the first exon of the mouse Ttr gene. To produce
LE+RE double mutant lox, six replacement vectors carry-
ing the different RE mutant lox-LacZ-pA-Pgk-Pac-loxP
were constructed, and the Ttr-KO41 line was coelec-
troporated with each replacement vector and a Cre-
expressing plasmid. We expected that intramolecular
recombination would initially occur, resulting in the
removal of the Pgk-neo cassette from the genome and
separation of the RE-mutant lox-LacZ-Pgk Pac cassette
from the plasmid backbone. Cre would then mediate
integrative recombination between chromosomal lox71
and the RE-mutant lox in the cassette. The Pac gene in
the replacement vector does not have a pA signal; there-
fore, random integrants should be puromycin-sensitive,
and cells should become drug-resistant only upon Cre-
mediated targeted integration during which the Pac gene
fuses to the pA signal. After coelectroporation, puromy-
cin-resistant colonies were selected, and the integration
pattern of the LacZ-pA-Pgk-Pac cassette was analyzed by
polymerase chain reaction (PCR), Southern blotting, and
sequencing (data not shown). Six sub-clones (71/66-P, 71/
JTZ-P, 71/KR1-P, 71/KR2-P, 71/KR3-P, and 71/KR4-P)
carrying different double mutant lox comprising the LE
mutation of lox71 and the RE mutation of each RE
mutant lox were established.
We first examined the short-term stability of these dou-
ble mutant lox. Linearized CAG-Cre-IRES-Hyg cassette
(pCAGNintCreIH) was introduced into each sub-clone,
and Cre-expressing transformants were selected with
hygromycin (hyg). Recombination between double
mutant lox and loxP results in removal of the puromycin
(puro) resistant genes; therefore, recombined cells
become puro-sensitive. If recombination occurs soon
after introduction of the CAG-Cre-IRES-Hyg cassette,
hyg-resistant (hygR) colonies should be puro-sensitive
(puroS). In the formation of entire hygR puroS colonies,
recombination should occur before the first cell division,
or, if formation occurs after the first cell division, recom-
bination should occur in all of the daughter cells. There-
fore, in this assay, it is possible to observe recombination
within 24-48 h after exposure to Cre protein. To estimate
the percentage of such hygR puroS colonies, electropo-
rated cells were divided into two plates. After 5 days of
hyg selection, one plate was selected with puro and the
other plate was fed with normal medium to obtain the
Table 1: Frequency of site-specific integration
Cell line lox66 loxJTZ17 loxKR1 loxKR2 loxKR3 loxKR4
Bs2 13.4 ± 4.3 18.0 ± 5.4 13.9 ± 2.5 19.2 ± 6.9 18.0 ± 2.4 17.5 ± 1.2
Bs17 11.3 ± 0.6 17.2 ± 2.2 13.3 ± 1.5 22.7 ± 3.3 17.3 ± 2.4 17.5 ± 3.7
Bs19 14.2 ± 2.9 13.3 ± 3.1 10.5 ± 1.8 18.0 ± 5.7 11.9 ± 3.4 12.9 ± 1.1
Bs21 13.8 ± 1.3 15.8 ± 2.6 14.4 ± 2.3 18.9 ± 3.6 13.9 ± 4.5 16.9 ± 2.7
Twenty micrograms of the integration plasmid and 10 μg of the Cre-expressing vector were coelectroporated. After drug selection for 7 days, 
colonies were stained with X-gal, and the percentage of positive colonies was scored as the frequency of site-specific integration. The means 
± SD of three independent electroporations are represented.
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hygR colonies represents the short-term stability of dou-
ble mutant lox site.
As shown in Figure 5, all double mutant lox showed
over 85% stability of inserted DNA, indicating that
recombination between double mutant lox and loxP
occurs only slightly over a short time period (24-48 h) in
ES cells. Although the/ox71/KR3 double mutant showed
higher stability than did the others, there was no signifi-
cant difference among double-mutant lox sites (p = 0.12).
These results are consistent with the observation that
there was no difference in integrative recombination.
In this short-term assay, we could not detect whether
recombination occurred later during colony formation in
a limited population of the colony because such recombi-
nation generates countable, partly puro-resistant (puroR)
colonies mixed with recombined puroS cells and un-
recombined puroR cells. To establish the stability of dou-
ble mutant lox sites against prolonged and strong Cre
expression, we cloned and cultured Cre-expressing sub-
lines, then examined the level of recombination by South-
ern blotting. Three double mutant lox lines, 71/66-P, 71/
JTZ-P, and 71/KR3-P, were selected for the analysis of
long-term stability (Figure 4, right side panel). After
introduction of the CAG-Cre-IRES-Hyg cassette and col-
ony formation, six Cre-expressing sub-lines from each
parental line were isolated and stocked. Cre expression
levels in the sub-lines were analyzed by northern blotting
(Figure 6a), and the two highest Cre-expressing lines were
selected from each double mutant lox parental line, as
indicated in Figure 6a. The selected lines were then pas-
saged 9~11 times from the original cell stock, and
genomic DNA was prepared after 1, 4, 7, 9, and 11 pas-
Figure 5 Short-term stability of double mutant lox sites. The ratios 
of hygR puroS colonies to hygR colonies from four independent elec-
troporations are represented. Bars indicate the means.
Figure 4 Strategy to evaluate the stability of double mutant lox. 
In the Ttr-KO41 line, the lox71-Pgk-neo-loxP-pA-lox2272 cassette was 
inserted in the first exon of the mouse Ttr gene. Replacement vectors 
carried the RE mutant lox-LacZ-pA-Pgk-Pac-loxP. The Ttr-KO41 line was 
coelectroporated with the each replacement vector and the Cre-ex-
pressing plasmid; it was then selected with puromycin. Colonies were 
picked, and six sub-clones (71/66-P, 71/JTZ-P, 71/KR1-P, 71/KR2-P, 71/
KR3-P, and 71/KR4-P) carrying different double mutant lox were estab-
lished. To induce stable Cre-expression, the CAG-Cre-IRES-Hyg trans-
gene was introduced into each sub-clone and selected with 
hygromycin. For the short-term stability assay, electroporated cells 
were divided into two plates, and after 5 days of hyg selection, one 
plate was selected with puro and the other with normal medium. The 
ratio of hygR puroS colonies to hygR colonies represents the short-term 
stability of the double mutant lox site. For the long-term stability assay, 
Cre-expressing sub-lines with high levels were selected and passaged 
9~11 times. Genomic DNA was prepared after 4, 7, 9, and 11 passages, 
and recombination at each stage was detected with Southern blot-
ting.
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cre gene was maintained during passage, total RNAs after
1, 7, and 11 passages were also prepared and subjected to
northern blotting. As shown in Figure 6b, the cre gene
was expressed with similar intensity during the 11 pas-
sages. Then, recombination between double mutant lox
and loxP sites at each stage was analyzed by Southern
blotting, as shown in Figure 7. In 71/66-P-Cre clones, the
band for the excised allele was detected clearly at passage
one, and the intensity became stronger with increasing
passage number (Figure 7a). On the other hand, the
bands for the excised allele in 71/JTZ-P-Cre and 71/KR3-
P-Cre clones were faint (Figure 7b and 7c), indicating that
lox71/JTZ and lox71/KR3 double mutant lox sites were
more stable than lox71/66.
To estimate the rate of allele excision, band intensities
relative to the band derived from the endogenous Pgk
gene were measured (Figure 7d, solid and hatched lines),
and the percentages of excised alleles were calculated
(Figure 7d, gray line). In 71/66-P-Cre clones, the rates of
allele excision were 48% (clone No. 1) and 74% (clone No.
4), suggesting that the lox71/66 double mutant is not
highly resistant to re-recombination with loxP under con-
tinuous exposure to Cre expression. In 71/JTZ-P-Cre and
71/KR3-P-Cre clones, the rates of allele excision were
under 21%, meaning that about 80% of double mutant lox
sites were not recombined, even under the strong Cre
expression forced by the CAG promoter (Figure 7d., mid-
dle and below).
In order to compare Cre expression levels in these Cre
sub-clones, the band intensities shown in Figure 6b were
measured by densitometry, and Cre expression level rela-
tive to 71/JTZ-P-Cre 4 was calculated. Figure 8 shows a
scatter plot of the rate of excision (y-axis) and Cre expres-
sion level (x-axis) in each sub-clone. In 71/JTZ-P-Cre and
71/KR3-P-Cre clones, excision rate and Cre expression
levels seemed to have a linear relationship with a similar
correlation coefficient, suggesting that lox71/JTZ17 and
lox71/KR3 have an in-affinity (stability) level similar to
Cre protein. On the other hand, 71/66-P-Cre clones
showed 2-4 times higher excision levels than did 71/JTZ-
P-Cre and 71/KR3-P-Cre clones.
Thus, lox71/JTZ17 and lox71/KR3 are highly resistant
to the Cre protein, but lox71/66 can be recombined with
loxP when the cre gene is expressed strongly and consti-
tutively. Therefore, if we used stable transformants of the
cre gene for site-directed integration experiments, lox66
should show a lower efficiency because of its higher rate
of re-excision.
Conclusions
In this study, we screened for RE mutant lox sites showing
higher recombination efficiency with lox71 using ES cells.
Although we could not identify any RE mutant lox with a
Figure 6 Northern blot analysis of Cre-expressing sub-lines. (a) Six sub-lines carrying the CAG-Cre-IRES-Hyg cassette were isolated from each of 
three double-mutant lox lines: 71/66-P, 71/JTZ-P, and 71/KR3-P. Ten micrograms of total RNA were subjected to electrophoresis and hybridization with 
a Cre probe. The two highest Cre-expressing lines selected from each of the six sub-lines are indicated by a circle. (b) Selected sub-lines were passaged 
11 times, and RNAs from 1st, 7th, and 11th passage were prepared. Four micrograms of total RNAs were subjected to electrophoresis and hybridization 
with a Cre probe. The expression levels of Cre were maintained during passages.
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two RE mutant lox, loxJTZ17 and loxKR3, produced
more stable (less inactive) double mutant lox with lox71
than did lox66/71. These two mutant RE lox sites would
therefore be more suitable than lox66 for Cre-mediated
integration or inversion in ES cells.
Methods
Plasmids
Plasmids pCAGGS-Cre, pCAGlox71bsr, and
plox66NZneo have been described previously [17,20].
The loxJTZ17 and loxKR1, 2, 3 and 4 sequences (Figure
1c) were synthesized, and the lox66 sequence of
Figure 7 Excising recombination between double mutant lox and wild-type loxP in strongly Cre-expressing sub-lines. (a) Restriction endo-
nuclease map of the targeted Ttr locus before (Ttr LacZ-KI allele) and after (Excised allele) Cre-mediated recombination. The pA signal of the mouse 
Pgk gene was used as a probe (indicated by the solid line). Fragment sizes are indicated. Bg, BglII; Sc, ScaI. (b) Southern blot analysis of Cre-expressing 
sub-lines. P represents the parental line before introducing the CAG-Cre-IRES-Hyg cassette. The numbers indicate passage numbers from the original 
cell stock. The positions of the bands from the nonexcised LacZ allele (LacZ), excised allele (Excised), and endogenous Pgk gene (Endo) are indicated 
by arrowheads. (c) Relative band intensities of the LacZ allele (hatched line) and excised allele (solid line) to the band intensities of the endogenous 
Pgk gene. The rate of excised band [ratio of excised band intensity to total (LacZ + excised) intensity] was calculated and is indicated by the gray line.
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sequences to produce pJTZNZneo, pKR1NZneo,
pKR2NZneo, pKR3NZneo, and pKR4NZneo (RE loxN-
Zneo plasmids). The p66NZPPacP plasmid was con-
structed by replacing the splice acceptor- enhanced green
fluorescent protein (EGFP) cassette of p6SEFPPF [19]
into the LacZ gene fused with the nuclear localization
signal (NLS) derived from the SV40 large T gene (NLS-
LacZ). The pJTZNZPPacP, pKR1NZPPacP,
pKR2NZPPacP, pKR3NZPPacP, and pKR4NZPacP (RE
loxNZPacP plasmids) were constructed by replacing the
lox66 sequence with the loxJTZ17 and loxKR1, 2, 3, and 4
sequences, respectively. The sequences of all lox sites in
these plasmids were confirmed by DNA sequencing.
The Cre-expression vector, pCAGNintCreIH, was
assembled from components of pSP73 (Promega, USA),
the CAG promoter [21], the NLS-splice donor (SD)-
intron-splice acceptor (SA)-cre cassette [22], the internal
ribosomal entry site (IRES) from the encephalomyocardi-
tis virus (ECMV), the hygromycin-resistance gene, and
the polyadenylation signal (pA) from the mouse phospho-
glycerate kinase-1 (Pgk) gene.
ES Cell cultures
ES cells were cultured in KSR-GMEM medium consisting
of Glasgow Minimum Essential Medium (GMEM)
(Sigma, USA) with 1× MEM nonessential amino acids
(Gibco Invitrogen, USA), 0.1 mM β-mercaptoethanol, 1
mM sodium pyruvate, 1% fetal bovine serum (FBS;
HyClone, Thermo Fisher Scientific Inc., USA), 14%
Knockout™ Serum Replacement (KSR; Gibco Invitrogen),
and 1100 U/ml leukemia inhibitory factor (LIF; ESGRO,
Chemicon, USA). For neutralization of trypsin, FCS-
GMEM in which the KSR in KSR-GMEM was replaced
with FBS (final concentration, 15% FBS) was used.
ES cell lines (Bs2, Bs17, Bs19, and Bs21) carrying the
target lox71 site were established from CGR8 [23] (Gift
from Dr. Niwa) by introducing 10 μg of SpeI-digested
pCAGlox71bsr plasmid DNA. ES cells (3 × 106 cells/0.8
ml in PBS) were electroporated using a Bio-Rad Gene
Pulser (Bio-Rad, USA) set at 200 V and 960 μF and plated
into two 10-cm plates. Blasticidin S selection was started
after 48 h of electroporation at 4 μg/ml for 7 days, and
colonies were picked, expanded, and stocked. Clones with
a single copy integration were selected by Southern blot-
ting analysis.
For Cre-mediated integration, ES cells were coelec-
troporated with 20 μg of RE loxNZneo plasmid and 10 μg
of pCAGGS-Cre at 400 V and 250 μF. G418 selection at
600 μg/ml for 7 days was started after 24 h of electropora-
tion. The colonies were then stained with X-gal.
The ES cell line Ttr-KO-41, which carries a lox71-Pgk
promoter-neomycin phosphotransferase (neo) gene-
loxP-pA cassette in the first exon of the Ttr gene (Ttrneo),
has been described previously [24]. To obtain site-spe-
cific integrants of RE loxNZPacP cassette into the Ttrneo
allele, Ttr-KO-41 ES cells were coelectroporated with 20
μg of RE loxNZPacP plasmid and 10 μg of pCAGGS-Cre
at 400 V and 250 μF. Puromycin selection was started
after 48 h at 2 μg/ml for 7 days. Colonies were picked and
stocked. For electroporation of pCAGNintCreIH, ES cells
were electroporated with 20 μg of XhoI-digested pCAG-
NintCreIH at 400 V and 250 μF and were fed 150 μg/ml of
hygromycin B-containing medium after 24 h of elec-
troporation. Hygromycin B selection was maintained for
5 days; we then changed to puromycin selection at 2 μg/
ml or to normal medium for 2 days.
Analyses of DNA and RNA
Cells were lysed with sodium dodecyl sulfate (SDS)/pro-
teinase K, treated with 1:1 (vol/vol) phenol/chloroform,
precipitated with ethanol, and dissolved in 10 mM Tris-
HCl, pH 7.5/1 mM ethylenediaminetetraacetic acid (TE).
Six micrograms of genomic DNA were digested with
appropriate restriction enzymes, electrophoresed in a
0.9% agarose gel, and blotted onto a nylon membrane
(Roche, Switzerland). Hybridization was performed using
a DIG DNA Labeling Kit (Roche). The intensities of the
obtained bands were determined using Printgraph AE-
6920-MF (ATTO, Japan).
Total RNA was isolated from ES cells using Sepasol
(Nakalai, Japan). Ten micrograms of total RNA were elec-
trophoresed through 1.0% agarose-formaldehyde gels and
transferred to a positively charged nylon membrane
Figure 8 Relation of excision and Cre expression level. The north-
ern blot X-ray film of Figure 6b was subjected to densitometry; the av-
erage of band intensities of samples from the 1st, 7th, and 11th 
passages were calculated; and the relative band intensity to 71/JTX-P-
Cre 4, which showed the lowest expression, was calculated and plot-
ted on the x-axis. The highest value of the excised allele rate calculated 
in Figure 7c was plotted on the y-axis. In 71/66-P-Cre clones, the re-
combination rate was apparently higher than in other clones.
Araki et al. BMC Biotechnology 2010, 10:29
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Page 9 of 9(Roche). Hybridization was performed using a DIG RNA
Labeling and Detection Kit (Roche).
Statistical analyses
The recombination efficiencies and relative number of
blue or white colonies were evaluated by nonrepeated
measures analysis of variance (ANOVA). Where a signifi-
cant difference (p < 0.05) was identified, the differences
were analyzed further with Student-Newman-Keuls
(SNK) tests for multiple comparisons.
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